YOLFTbeta
Resverlogix Corp.

Resverlogix Corp.

RVX · TO · Healthcare / Biotechnology

0.075CAD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.075
Open0.075
Day Range0.075 – 0.075
52-Week Range0.085 – 0.15
Volume36.00K
Market Cap29.26M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.04
Dividend Yield0.00%
Beta1.06
50-Day Avg0.0986
200-Day Avg0.103

About

Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for patients with chronic illnesses. Its lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor for patients with cardiovascular disease, chronic kidney disease, type 2 diabetes mellitus, low high-density lipoprotein, recent acute coronary syndrome, and post COVID-19 conditions. The company has a partnership with Eversana Life Science Services, LLC to support the commercialization of apabetalone for COVID-19 in the United States and Canada; developing cardiovascular and pulmonary arterial hypertension indications; and Medison Pharma Ltd. The company is headquartered in Calgary, Canada.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Donald J. McCaffrey
  • Employees0
  • Headquarters4820 Richard Road SW, Calgary, AB, Canada, T3E 6L1, Canada
  • Websitehttps://www.resverlogix.com

Leadership

  • Mr. Donald J. McCaffreyCo-Founder, Chairman, President, CEO & Secretary
  • Mr. Aaron Bradley Cann C.A., CPA, CBVChief Financial Officer
  • Dr. Ewelina Kulikowski Ph.D.Chief Scientific Officer
  • Dr. Michael Sweeney M.D.Senior Vice President of Clinical Development · b. 1961

Financials

Income Statement

Currency: USD2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue5.90K-17.59K175.06K243.64K289.95K-138.17K2.80K82.88K--0000000000000
Growth (%)---+895.15%+39.18%+19.01%---97.97%+2856.13%---------------
Cost of Revenue------------00000-----729.50K476.75K437.53K
Gross Profit5.90K-17.59K175.06K243.64K289.95K-138.17K2.80K82.88K--00000------729.50K-476.75K-437.53K
Gross Margin100.00%-100.00%100.00%100.00%100.00%-100.00%100.00%100.00%---------------
Operating Expense45.08K-1.41M3.05M6.59M16.18M-19.30M22.08M22.20M--14.04M8.46M20.01M34.14M30.90M-----5.53M5.89M4.77M
Operating Income-39.18K-512.83K-1.39M-2.87M-6.35M-15.89M-24.82M-19.17M-22.08M-22.12M-24.76M-34.64M-14.04M-8.46M-20.01M-34.14M-30.90M-38.74K-22.58M-14.57K-15.97M-12.75M-6.26M-6.37M-5.20M
Operating Margin-663.84%--7903.73%-1639.97%-2606.87%-5478.74%--13871.44%-787525.33%-26691.77%---------------
EBITDA-39.18K-490.21K-1.28M-2.76M-6.14M-15.37M-24.36M-18.95M-21.84M-21.82M-24.18M26.25M73.41M3.54M-26.21M-28.82M-30.54M-38.41K-74.15M-14.20K-14.87M-11.74M-4.82M-4.25M-4.77M
EBITDA Margin-663.84%--7300.84%-1574.34%-2518.92%-5299.54%--13711.86%-778965.11%-26326.67%---------------
Net Income-39.18K-512.83K-1.41M-2.84M-6.38M-16.55M-28.13M-18.10M-27.47M-22.12M-18.78M43.35M-55.10M18.32M-19.71M-46.21M-58.31M-162.80K118.03M2.46K-24.77M-3.61M-16.74M-7.63M-7.90M
Net Income Margin-663.84%--8020.21%-1620.79%-2620.11%-5707.10%--13101.81%-979685.04%-26691.77%---------------
R&D-194.13K263.92K1.25M3.03M9.57M14.60M11.40M15.11M14.42M19.74M28.43M9.81M4.18M15.68M29.88M37.79M32.34K15.80M6.40K4.51M5.51M3.25M2.85M2.77M
R&D as % of Total Revenue--1500.33%714.04%1244.24%3299.97%-8254.42%538800.79%17394.09%---------------
Interest Expense39.18K020.49K33.58K32.27K159.56K167.16K2.09M1.20M06.10M18.95M3.71M5.82M6.19M7.03M5.45M5.63M3.57M2.98M727.00K1.63M1.87M4.20M4.33M
Interest Expense % of Total Revenue663.84%-116.48%19.18%13.25%55.03%-1511.78%42743.54%0.00%---------------

Balance Sheet

Currency: USD2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets295.29K1.08M2.69M10.20M8.06M15.00M20.71M18.91M8.43M8.43M12.37M20.50M3.03M21.16M40.10M10.87M8.28M16.29M11.38M10.71M9.98M8.12M6.57M7.34M7.93M
Total Liabilities35.65K139.85K97.60K353.37K579.36K16.02M15.27M7.30M3.97M4.13M9.63M50.00M66.24M94.88M96.53M112.44M91.95M224.01M75.49M50.60M69.85M67.40M81.04M89.08M96.73M
Total Equity259.64K942.21K2.60M9.84M7.48M-1.02M5.44M11.61M4.46M4.30M2.74M-29.50M-63.22M-73.73M-56.43M-101.57M-83.68M-207.72M-64.11M-39.90M-59.87M-59.28M-74.47M-81.73M-88.80M
Cash294.63K597.48K201.47K6.68M2.74M490.37K2.33M10.52M4.54M4.80M7.56M17.41M590.00K16.21M28.11M1.35M121.00K7.69M4.00K87.00K6.00K40.00K5.00K99.00K107.80K
Total Debt-14.34K45.75K26.11K-13.27M12.10M4.83M---26.66M26.47M117.27M129.63M48.64M708.00K14.77M13.16M996.00K7.04M6.49M9.91M81.97M72.77M
Net Debt-294.63K-583.13K-155.72K-6.65M-2.74M12.78M9.77M-5.69M-4.54M-4.80M-7.56M9.24M25.88M28.53M19.61M47.28M587.00K7.08M13.15M-877.03M6.45M9.90M81.87M72.66M

Cash Flow

Currency: USD2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-10.98K-453.56K-885.04K-2.18M-4.41M-9.93M-19.65M-13.01M-18.34M-19.24M-24.03M-29.00M-13.20M-8.50M-21.42M-22.67M-25.13M-48.83M-17.34M-4.40K-8.02M-3.54M-2.51M-3.89M-3.73M
Investing Cash Flow--380.02K-7.77K-788.82K-1.45M-7.64M-3.99M6.97M5.93M-387.36K-565.00K-545.00K-8.09M-2.11M-710.00K-652.00K-360.00K-731.00K-576.00K-426-833.00K-473.00K-516.00K-377.00K-660.36K
Financing Cash Flow184.88K1.19M470.22K9.43M1.06M15.29M25.43M14.60M5.27M19.72M27.48M39.59M4.79M28.38M35.18M-2.38M23.30M57.14M10.17M4.95K8.81M4.06M2.99M4.36M4.39M
Capital Expenditure0438.22K94.46K145.70K585.53K820.56K536.97K203.75K350.52K402.12K565.00K545.00K771.00K1.81M788.00K559.00K537.00K622.00K500.00K13877.00K450.00K448.00K472.00K9.16K
Free Cash Flow-10.98K-891.78K-979.51K-2.33M-5.00M-10.75M-20.18M-13.21M-18.69M-19.64M-24.59M-29.54M-13.97M-10.31M-22.21M-23.23M-25.67M-49.46M-17.84M-4.41K-8.90M-3.99M-2.96M-4.36M-3.73M
Dividends Paid--------------0000000-000
FCF to OCF100.00%196.62%110.67%106.68%113.28%108.27%102.73%101.57%101.91%102.09%102.35%101.88%105.84%121.28%103.68%102.47%102.14%101.27%102.88%100.30%110.93%112.71%117.83%112.15%100.25%
Dividend Paid to FCF--------------0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.00%0.00%0.00%

Earnings

Report DateJan 31, 2003Apr 30, 2003Jul 31, 2003Oct 31, 2003Jan 31, 2004Apr 30, 2004Jul 31, 2004Oct 31, 2004Mar 4, 2005Jun 29, 2005Sep 8, 2005Dec 12, 2005Mar 7, 2006Jul 19, 2006Sep 12, 2006Dec 12, 2006Mar 14, 2007Mar 19, 2007Jun 28, 2007Jun 29, 2007Sep 12, 2007Sep 13, 2007Dec 7, 2007Dec 11, 2007Mar 12, 2008Jul 28, 2008Sep 12, 2008Dec 9, 2008Mar 11, 2009Jul 28, 2009Sep 11, 2009Dec 15, 2009Mar 15, 2010Jul 27, 2010Sep 11, 2010Dec 15, 2010Mar 17, 2011Jul 21, 2011Sep 12, 2011Dec 15, 2011Mar 15, 2012Jul 24, 2012Sep 10, 2012Dec 13, 2012Mar 14, 2013Jul 26, 2013Sep 13, 2013Dec 13, 2013Mar 18, 2014Jul 30, 2014Sep 12, 2014Dec 11, 2014Mar 12, 2015Jul 24, 2015Sep 9, 2015Dec 14, 2015Mar 15, 2016Jul 27, 2016Sep 14, 2016Dec 13, 2016Mar 17, 2017Jul 25, 2017Sep 13, 2017Dec 14, 2017Mar 16, 2018Jul 30, 2018Sep 14, 2018Dec 13, 2018Mar 15, 2019Mar 31, 2019Jul 29, 2019Sep 16, 2019Dec 16, 2019Mar 13, 2020Sep 11, 2020Oct 2, 2020Dec 14, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024May 14, 2024Jun 30, 2024Nov 7, 2024Dec 31, 2024Jun 4, 2025Aug 14, 2025Nov 12, 2025Mar 31, 2026May 14, 2026Aug 13, 2026Nov 12, 2026
EPS Estimate------------------0.14-0.18---0.26-0.29--------0.15-0.14-0.14-0.10--0.12-0.11-0.11--0.09------0.10-0.020.22---0.04-0.03-0.04-0.04--0.04-0.03---0.08-0.09--0.14-0.12-0.09---0.08-0.04-0.04-0.02-0.13-0.14----------------------------
EPS Actual-0.02-2.04-0.03-0.01-0.02-1.33-0.03-0.04-0.05-0.05-0.06-0.09-0.06-0.09-0.08-0.13-0.19-0.19-0.36-0.36-0.28-0.28-0.31-0.31-0.24-0.27-0.19-0.20-0.26-0.13-0.14-0.120.21-0.19-0.11-0.10-0.09-0.11-0.02-0.07-0.10-0.11-0.11-0.14-0.17-0.160.55-0.020.200.01-0.09-0.05-0.03-0.320.04-0.05-0.11-0.13-0.08-0.18-0.16-0.15-0.17-0.13-0.20-0.06-0.36-0.28-0.09-0.09-0.34-0.03-0.030.030.060.06-0.020.00-0.01-0.03-0.09-0.01-0.00-0.010.00-0.03-0.02-0.02-0.020.000.00-0.02-0.020.00-0.03-0.01-0.00-0.00-0.02-0.03-
Surprise------------------35.71%-100.00%---7.69%-6.90%-------6.67%14.29%250.00%-90.00%-16.67%18.18%0.00%-22.22%------60.00%2850.00%-109.09%---125.00%-66.67%25.00%-700.00%--25.00%-266.67%---125.00%-77.78%--21.43%-8.33%-122.22%---250.00%-125.00%-127.80%-1600.00%76.92%80.37%----------------------------
Timing-----------------Pre-marketPre-market--After-hoursPre-market-------After-hoursAfter-hoursAfter-hours--After-hoursAfter-hours---------After-hoursAfter-hours--After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hours-------------After-hours-After-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap29.26M
Enterprise Value60.62M
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales1275.46
Price / Book47.93
EPS-0.04
Book Value-0.3904
Revenue (TTM)0
Gross Profit (TTM)0
EBITDA-4.77M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity0.00%
Return on Assets-40.29%
Shares Outstanding344.29M
Shares Float251.22M
Beta1.06
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%